Tag: Medication shortage

While the global market for magnesium supplements is projected to see steady growth, recent and past events have led to specific product shortages, causing consumer concern about overall availability. In response to the question, "Is there a magnesium supplement shortage?", the answer is complex and depends heavily on the specific product and time frame in question, rather than a universal scarcity.

Following a national drug shortage that was officially declared resolved by the FDA in December 2024, intermittent local and regional supply issues for Zepbound can still occur. This makes knowing how to find a pharmacy with Zepbound in stock a crucial part of managing your treatment plan.

In December 2024, the U.S. Food and Drug Administration (FDA) officially declared the tirzepatide drug shortage resolved, significantly altering how patients can access this medication. For those previously relying on compounded versions, this regulatory shift raises a critical question: **Am I still going to be able to get tirzepatide?**.

In 2022, an estimated 9.3 million adults in the U.S. needed treatment for opioid use disorder (OUD), yet only a fraction received it [1.8.2]. This makes the current supply crisis critical, leading patients and providers to ask: **why is buprenorphine on backorder?** [1.2.2, 1.8.2]

An estimated 4.22 million Americans live with glaucoma, a condition often managed with pressure-lowering medications [1.8.1]. A key question for many is: **Is dorzolamide-timolol eye drops discontinued?** While some brand-name versions have been discontinued, generic options remain widely available.

In 2014, the FDA determined that the brand-name Diamox tablets and intravenous solution were not withdrawn for safety or effectiveness reasons, despite being listed as discontinued. This clarification is crucial for patients asking, 'Is Diamox being discontinued?' because the active ingredient remains widely available.

Wegovy received marketing authorization valid throughout the European Union on January 6, 2022, following a positive assessment by the European Medicines Agency (EMA). Despite this blanket approval, the question "**Is Wegovy banned in Europe for weight loss?**" frequently arises due to significant variations in national launches, reimbursement policies, and persistent supply challenges across the continent.

High demand has historically caused shortages of semaglutide-based drugs like Ozempic, prompting many patients to ask, what do I do if my Ozempic is out of stock?. While recent supply issues have improved, intermittent local disruptions can still occur, making it crucial to have a plan to ensure continuity of your treatment.

According to the American Society of Health-System Pharmacists (ASHP), the US faced over 300 active drug shortages at the end of 2023, the highest number since recordkeeping began. For many patients starting their weight loss journey, a common concern is the availability of their medication, leading to the question: **is Zepbound 7.5 hard to get?** While supply issues previously affected certain doses, the national shortage for Zepbound was officially resolved by the FDA in late 2024, though localized issues and high demand can still present challenges.

According to manufacturer announcements and information shared by the FDA, all versions of the type 2 diabetes medication Bydureon and its predecessor, Byetta, were officially discontinued in October 2024. While a widespread **Is there a shortage of Bydureon?** issue existed previously due to high demand for GLP-1 medications, the current unavailability is a result of a permanent business decision by the manufacturer, not a temporary supply problem.